Skip to main content

DORB News

Feuerstein's Biotech-Stock Mailbag

This week: Pipex, Hythiam, Amgen and Isis.

10 Biotech Stocks Facing FDA Judgment Day

These names have important regulatory hurdles ahead.

Activist Hates Alcoa Deal

Jana's pan of the hostile bid for Alcan made the aluminum giant Stockpickr's top activist situation.

Feuerstein's Biotech Mailbag

Finding little value in Antigenics' Oncophage, much in Hep C and caution in Dor.

Feuerstein's Biotech Mailbag

Less on Dendreon, sort of; Provenge déjà vu, GenVec and Medarex, at last.

Breaking News

Gap Stock Slumps On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.